• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

SR One

edit

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately $600 million in more than 130 companies. For more information please visit www.srone.com

Milestones

edit

• 
  SR One invested in Trinity Biosystems. (11/9/09)
  Posted 11/10/09 at 1:46am
• 
  SR One invested in Aileron Therapeutics. (6/11/09)
  Posted 6/15/09 at 10:24pm
• 
  SR One invested in Anaphore. (6/9/09)
  Posted 6/16/09 at 10:25am
• 
  SR One invested in CalciMedica. (1/4/09)
  Posted 6/15/09 at 7:24pm
• 
  SR One invested in POINT Biomedical. (1/08)
  Posted 6/17/09 at 6:49pm

Investments

Videos

Sources

1. Trinity Biosystems raises $7.5M bridge to treat endocrine disorders (deals.venturebeat.com) [edit]
2. Aileron Therapeutics Closes Series D Financing (zibb.com) [edit]
3. Anaphore, Inc.: Series A $13M (onbiovc.com) [edit]
4. CalciMedica, Inc.: Series C $4M (onbiovc.com) [edit]
5. Capital Funding Report [edit]